AI chatbot could be a new tool in opioid recovery
NCT ID NCT06845878
First seen Apr 25, 2026 · Last updated May 01, 2026 · Updated 1 time
Summary
This study tests whether an AI chatbot can support people recovering from opioid use disorder. Participants use the chatbot for 12 weeks to prepare for appointments, find resources, and learn wellness techniques. The goal is to see if the chatbot reduces drug use, improves clinic attendance, and helps patients feel more in control of their recovery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OPIATE-RELATED DISORDERS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Massachusetts General Hospital
Boston, Massachusetts, 02114, United States
Conditions
Explore the condition pages connected to this study.